Another Major European Airport Selects Implant Sciences' QS-B220 Explosives and Drugs Trace Detector for Aviation Security
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today announced it has sold and shipped its Quantum Sniffer™ QS-B220 desktop explosives and drugs trace detector to a major European airport. This marks the third major European airport to select the QS-B220 for aviation security within the last four months.
"We are pleased to have won this contract in a competitive bidding situation. Our QS-B220 was selected over competing systems by yet another well-known international European airport," stated Implant Sciences' Vice President of Sales and Marketing, Dr. Darryl Jones. "The customer conducted an extensive trial of the system, during which they we able to evaluate first hand our QS-B220's consistent and positive identification of a broad range of explosives and drugs, as well as the excellent level of local training and support provided by our distributor."
Global C4ISR Market Assessment
Source : Implant Sciences Corp.
Sep 15 - 17, 2014 - London, United Kingdom